Infectious Diseases in the Critically Ill Patients
- 1 February 2011
- journal article
- review article
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 24 (1) , 35-43
Abstract
Infection is common in the critically ill and often results due to the severity of the patient’s illness. Recent data suggest 51% of intensive care unit (ICU) patients are infected, and 71% receive antimicrobial therapy. Bacterial infection is the primary concern, although some fungal infections are opportunistic. Infection more than doubles the ICU mortality rate, and the costs associated with infection may be as high as 40% of total ICU expenditures. There are many contemporary antimicrobial resistance concerns that the critical care clinician must consider in managing the pharmacotherapy of infection. Methicillin resistance in Staphylococcus aureus, vancomycin resistance in Enterococci, beta-lactamase resistance in Enterobacteriaceae, multidrug resistance in Pseudomonas aeruginosa and Acinetobacter species, fluoroquinolone resistance in Escherichia coli, and fungal resistance are among the most common issues ICU clinician’s must face in managing infection. Critical illness causes changes in pharmacokinetics that influence drug and dosing considerations. Absorption, distribution, metabolism, and excretion may all be affected by the various disease states that define critical illness. Several specific diseases are discussed, including ventilator-associated pneumonia, various fungal infections, gastrointestinal infections due to Clostridium difficile, urinary tract infections, and bloodstream infections. Within each disease section, discussion includes causes and prevention strategies, microbiology, evidence-based guidelines, and important caveats.Keywords
This publication has 50 references indexed in Scilit:
- International Study of the Prevalence and Outcomes of Infection in Intensive Care UnitsJAMA, 2009
- The ecology, epidemiology and virulence of EnterococcusMicrobiology, 2009
- Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococciClinical Microbiology and Infection, 2009
- The Immune System in Critical IllnessClinics in Chest Medicine, 2008
- Antimicrobial Therapy Escalation and Hospital Mortality Among Patients With Health-Care-Associated PneumoniaChest, 2008
- Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysisJournal of Critical Care, 2008
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- Pseudomonas aeruginosaBloodstream Infection: Importance of Appropriate Initial Antimicrobial TreatmentAntimicrobial Agents and Chemotherapy, 2005
- Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance StudyClinical Infectious Diseases, 2004
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001